Exact Sciences Corporation Stock
Stocks
EXAS
US30063P1057
Biotechnology & Medical Research
|
Delayed
Nasdaq
04:00:00 21/03/2026 HKT
|
5-day change | 1st Jan Change | ||
| 104.91 USD | +0.95% |
|
-.--% | +3.30% |
| 03-25 | Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Biotechnology Select Industry Index | CI |
| 03-25 | Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Global BMI Index | CI |
| Market Cap | 20.03B 17.89B 16.69B 15.16B 28.56B 1,937B 28.77B 201B 78.37B 985B 75.18B 73.56B 3,167B | P/E 2024 |
-10.1x | P/E 2025 | -92.2x |
|---|---|---|---|---|---|
| Enterprise Value | 21.6B 19.3B 18B 16.35B 30.8B 2,089B 31.03B 216B 84.52B 1,062B 81.08B 79.32B 3,416B | EV / Sales 2024 |
4.4x | EV / Sales 2025 | 6.42x |
| Free-Float |
98.24% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Exact Sciences Corporation
| 1 day | +0.95% | ||
| Current year | +3.30% |
| Current year | 101.51 |  | 104.98 |
| 1 year | 57.75 | | 104.98 |
| 3 years | 38.81 | | 104.98 |
| 5 years | 29.27 | | 104.98 |
| 10 years | 13.05 | | 159.54 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/3/26 | Issuer sale | Director | 28,899 | 0.0151% | ||
| 23/3/26 | Free | Executive/Senior Manager | 199,374 | 0.1044% | ||
| 23/3/26 | Issuer sale | Director | 20,558 | 0.0108% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.95% | -.--% | +82.04% | +67.32% | 20.03B | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| +0.46% | -0.97% | +23.51% | +79.57% | 58.81B | |
| +0.17% | +0.35% | +6.85% | +34.55% | 48.45B | |
| +0.58% | -1.72% | +333.15% | +691.99% | 42.84B | |
| -0.14% | -3.56% | +29.08% | +29.94% | 42.79B | |
| +0.53% | -0.22% | +6.88% | +111.31% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| +0.76% | -1.79% | -8.98% | -11.68% | 24.05B | |
| Average | +0.50% | -0.23% | +56.61% | +117.61% | 41.43B | |
| Weighted average by Cap. | +0.83% | -0.51% | +57.87% | +126.49% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.76B 2.47B 2.3B 2.09B 3.93B 267B 3.96B 27.64B 10.8B 136B 10.36B 10.13B 436B | 3.25B 2.9B 2.71B 2.46B 4.63B 314B 4.66B 32.53B 12.71B 160B 12.19B 11.93B 514B |
| Net income | -1.03B -919M -858M -779M -1.47B -99.53B -1.48B -10.31B -4.03B -50.62B -3.86B -3.78B -163B | -208M -186M -173M -157M -297M -20.12B -299M -2.08B -814M -10.23B -781M -764M -32.89B |
| Net Debt | 1.74B 1.55B 1.45B 1.32B 2.48B 168B 2.5B 17.41B 6.8B 85.49B 6.52B 6.38B 275B | 1.57B 1.4B 1.31B 1.19B 2.24B 152B 2.26B 15.73B 6.14B 77.24B 5.89B 5.77B 248B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- EXAS Stock
Select your edition
All financial news and data tailored to specific country editions
